BIODEL INC's ticker is BIOD and the CUSIP is 09064M204. A total of 36 filers reported holding BIODEL INC in Q2 2014. The put-call ratio across all filers is 1.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $602,000 | +26.7% | 1,394,085 | -8.8% | 0.00% | – |
| Q2 2016 | $475,000 | -1.0% | 1,528,974 | +5.1% | 0.00% | – |
| Q1 2016 | $480,000 | +25.7% | 1,455,033 | +30.5% | 0.00% | – |
| Q4 2015 | $382,000 | -99.8% | 1,114,814 | -83.3% | 0.00% | -100.0% |
| Q3 2015 | $174,473,000 | +24132.4% | 6,672,832 | +855.8% | 0.01% | – |
| Q2 2015 | $720,000 | +7.1% | 698,121 | +23.7% | 0.00% | – |
| Q1 2015 | $672,000 | -3.0% | 564,456 | +8.3% | 0.00% | – |
| Q4 2014 | $693,000 | -19.0% | 521,319 | +1.7% | 0.00% | – |
| Q3 2014 | $856,000 | -19.8% | 512,499 | +3.7% | 0.00% | – |
| Q2 2014 | $1,067,000 | -19.5% | 494,244 | +1.9% | 0.00% | – |
| Q1 2014 | $1,325,000 | +36.6% | 485,144 | +15.0% | 0.00% | – |
| Q4 2013 | $970,000 | -21.8% | 421,769 | +7.1% | 0.00% | – |
| Q3 2013 | $1,241,000 | -22.5% | 393,869 | +2.8% | 0.00% | – |
| Q2 2013 | $1,602,000 | – | 383,296 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FNY Managed Accounts LLC | 317,000 | $421,610,000 | 0.50% |
| Broadfin Capital, LLC | 2,660,068 | $3,538,000 | 0.15% |
| SABBY MANAGEMENT, LLC | 1,615,143 | $2,148,000 | 0.07% |
| SHEPHERD KAPLAN KROCHUK, LLC | 80,525 | $107,000 | 0.02% |
| Rotella Capital Management, Inc. | 12,524 | $17,000 | 0.02% |
| Orbimed Advisors | 209,700 | $279,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 98,524 | $131,000 | 0.00% |
| First Allied Advisory Services, Inc. | 20,000 | $27,000 | 0.00% |
| Plante Moran Financial Advisors, LLC | 1,470 | $2,000 | 0.00% |
| Renaissance Technologies | 180,755 | $240,000 | 0.00% |